10 most frequently asked questions about Merck (answered)

Have you ever wondered what people ask the most about Merck on the Internet? Well, you’ve come to the right place as we’ve gathered some of the most common Q&As online. In this article, we will answer the 10 most frequently asked questions about the German multinational science and technology company.

1. What is Merck?

Merck is a global healthcare company that focuses on developing and producing medicines, vaccines, and animal health products. Founded in 1668, it is the world’s oldest operating chemical and pharmaceutical company, with its headquarters in Darmstadt, Germany. Merck operates in Europe, Africa, Asia, Oceania, and the Americas, employing about 60,000 people across 66 countries.

2. What products does Merck offer?

Merck offers a wide range of products in three main business areas: Healthcare, Life Sciences, and Electronics. In healthcare, they produce prescription medicines, vaccines, and biologic therapies. Their life sciences division provides tools and services for scientific research and manufacturing, while the electronics sector focuses on specialty chemicals and materials for the technology industry.

3. How big is Merck?

Merck is one of the largest pharmaceutical companies in the world, with a presence in 66 countries and around 60,000 employees globally. In 2024, the company reported sales of $60.1 billion, demonstrating its significant size and influence in the healthcare industry.

4. Who leads Merck?

As of 2025, the Chairman and CEO of Merck is Robert M. Davis, who has been leading the company since 2020. Under his leadership, Merck has focused on areas like innovative medicines, vaccines, and animal health products to drive growth and improve global health.

5. What are Merck’s main research areas?

Merck’s main research areas include oncology, vaccines, infectious diseases, and animal health. The company invests heavily in research and development, with a focus on creating innovative solutions for unmet medical needs. They have research centers in various locations worldwide, including Darmstadt, Boston, Tokyo, and Beijing.

6. How does Merck contribute to global health?

Merck contributes to global health through its medicines, vaccines, and health initiatives. The company has programs to improve access to healthcare in low- and middle-income countries, such as the MECTIZAN Donation Program, which helps eliminate river blindness and lymphatic filariasis. Merck also works on developing new treatments for diseases that affect people worldwide.

7. What is Merck’s approach to sustainability?

Merck has committed to integrating sustainability into all its value chains by 2030. The company aims to reduce its environmental impact by improving energy efficiency, reducing waste, and using more renewable energy. In 2023, Merck sourced 57% of its purchased electricity from renewable sources and has set a goal to be net-zero across all greenhouse gas emissions by 2045.

8. How does Merck support innovation?

Merck supports innovation through substantial investments in research and development, collaborations with academic institutions and other companies, and by fostering a culture of creativity within the organization. The company also uses advanced technologies like artificial intelligence to accelerate drug discovery and development processes.

9. What is Merck’s stance on diversity and inclusion?

Merck values diversity and inclusion in its workforce and has implemented various initiatives to promote equality. In 2023, the company achieved greater than 99% parity in compensation between female and male employees, as indicated by its global pay equity study of more than 65,000 employees.

10. How does Merck engage with patients?

Merck takes a patient-directed approach in its work, aiming to incorporate patient perspectives into every aspect of its operations. The company gathers insights from thousands of patients and family carers each year to better understand their experiences and inform decision-making. Merck also collaborates with over 300 patient- and carer-led organizations globally to shape clinical trials, address public health priorities, and challenge social inequities.

Scroll to Top